Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Observational Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

NCT03755128 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT03755128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03755128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Observational Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
January 16, 2019
Completion date
September 22, 2023
Enrollment
17 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

early onset severe hemolytic disease of the fetus and newborn (eos-hdfn), erythroblastosis, fetal